27 May 2025 : Original article
Impact of Preoperative Treatment on Donor Hepatic Steatosis in Living Donor Liver Transplantation
Ahmet Atasever
ABCEF 1, Sinan Efe Yazıcı ABEF 1*, Tolga Şahin ABCF 1, Yıldıray Yuzer A 2
DOI: 10.12659/AOT.947772
Ann Transplant 2025; 30:e947772
Table 4 Postoperative laboratory parameters (peak levels).
| Patients receiving fatty liver treatment (n: 14) (mean±SD) | Patients not receiving fatty liver treatment (n: 20) (mean±SD) | P value | |
|---|---|---|---|
| AST | 250±91 | 263±135 | >0.05 |
| ALT | 331±131 | 265±116 | >0.05 |
| ALP | 146±69 | 174±81 | >0.05 |
| GGT | 384±299 | 402±298 | |
| Total bilirubin | 3.3±1.4 | 3.7±1.6 | |
| Direct bilirubin | 1.5±0.9 | 1.8±1.1 | >0.05 |
| INR | 1.65±0.31 | 1.69±0.28 | >0.05 |